Senores Pharmaceuticals IPO allotment: Check application status, latest GMP & listing date

Senores Pharmaceuticals is set to finalize the allotment of its shares on Thursday, December 26. Bidders should expect messages, alerts, or emails regarding the debit of their funds or revocation of their IPO mandate by Friday, December 27 at the latest. The pharmaceutical company received a robust response from investors during the three-day bidding period.

The company's IPO was open for bidding from December 20 to December 24. Shares were offered in the price band of Rs 372-391 per share with a lot size of 38 shares. The total amount raised from the IPO was Rs 582.11 crore, which included a fresh issue of Rs 500 crore and an offer-for-sale of up to 21,00,000 equity shares.

The issue was subscribed 93.41 times overall, due to widespread bidding. The portion for qualified-institutional bidders (QIBs) was subscribed about 94.66 times, while the portion for non-institutional investors (NIIs) was booked 96.11 times. The allocations for retail investors and employees were booked 89.23 times and 19.92 times, respectively.

Despite market volatility, the Grey Market Premium (GMP) of Senores Pharmaceuticals has remained steady. The company was last reported to command a premium of Rs 240 in the unofficial market, suggesting a listing pop of up to 60 per cent for investors.

Established in December 2017, Senores Pharmaceuticals develops and manufactures a variety of pharmaceutical products primarily for the regulated markets of the US, Canada, and the UK, while also catering to emerging markets. As of September 30, 2024, it had launched 55 products in key therapeutic areas, including antibiotics and anti-fungal treatments.

Equirus Capital, Ambit, and Nuvama Wealth Management are the book running lead managers of the Senores Pharmaceuticals IPO, with Link Intime India serving as the registrar for the issue. The company's shares are set to be listed on both NSE and BSE, with Monday, December 30, as the tentative listing date.

Investors who bid for the issue of Senores Pharmaceuticals can check the allotment status on the Bombay Stock Exchange (BSE) website by following these steps:

1) Visit https://www.bseindia.com/investors/appli_check.aspx

2) Click Equity under the issue type

3) Select Senores Pharmaceuticals Limited under the issue name

4) Enter the application number

5) Input the PAN card ID

6) Verify 'I am not a Robot' and click the search button

The allotment status can also be checked on the online portal of Link Intime India LINKINTIME , the registrar to the issue.

The registrar is a Sebi-registered entity, qualified to process all applications electronically and carry out the allotment process as per the prospectus. It is responsible for meeting the timelines for updating the electronic credit of shares to successful applicants, dispatching and uploading refunds, and handling all investor-related queries post issue.

To check the allotment status on Link Intime Limited's web portal, follow these steps:

1) Visit the web portal of Link Intime Limited

2) Select the IPO/FPO in the dropbox, which will only be populated if the allotment is finalized

3) Choose one of the three modes: Application number, Demat Account number, or PAN ID

4) Select between ASBA and non-ASBA in the application type

5) Enter the details of the mode selected in Step 3

6) Fill the captcha accurately for security purposes

7) Click submit.